THE COLLECTING DUCT (CD) is a heterogeneous tubule that contributes to water, electrolytes, and acid-base homeostasis. The CD is composed of principal (PC) and intercalated cells (IC). The PCs provide mainly for renal handling of water and electrolytes, while IC contributes to acid-base homeostasis.
These two cellular types originate from the same embryonic tissue, the ureteric bud. However, the differentiation process is not completely elucidated. A recent study from Blomqvist et al. (2) proposes an interesting model arising from Foxi1 null mice. Foxi1 null mice fail to express neither ␣-nor ␤-ICs, and they develop a form of distal renal tubular acidosis associated with deafness. The CD of these mice expresses cells double positive for aquaporin-2 (AQP2) and carbonic anhydrase but negative for the functional markers of ICs, the proton pump (H ϩ -ATPase) and the anion exchanger-1 (AE-1). This double-marked cell is considered an intermediate element between the embryonic cells of the ureteric bud and the fully differentiated PCs and ICs. Foxi1 seems to be fundamental for the fully differentiation of ICs. On the other hand, the complete differentiation of the PCs from their precursor requires the integrity of the Notch signal (11) . Thus different signaling cascades appear to be involved in the terminal differentiation of PC and ICs.
The ICs are extremely plastic (19) . They can switch from an acid to a basic secreting phenotype (and vice versa) according with the environmental acid-base status (1) . In addition, in vitro studies proposed an even more plastic ability in acquiring the functions of the PCs. Culture of sorted ␤-ICs can acquire an amiloride-sensitive sodium reabsorption and potassium-secreting ability (10) .
Lithium (Li ϩ ) salts are first line therapy for bipolar mood disorder. Nephrogenic diabetes insipidus (NDI) is the most frequent side effect of Li ϩ treatment accounting for ϳ50% of the patients (24) . Recently, we have shown that chronic Li ϩ treatment induces a cellular reorganization of the CD, increasing the number of type-A IC (A-IC). These cellular changes revert after 1 mo of Li ϩ washout (6) . This reversal could be sustained by either increased proliferation of PCs coupled with apoptosis of A-IC (cellular turnover) or by intercellular conversion among these two cell types or differentiation of renal progenitors.
The mechanisms involved in the amelioration of the symptoms of NDI after the discontinuation of lithium are poorly studied. Here we focused on the time course of the recovery from Li ϩ -induced NDI in rats. We have identified in vivo a novel cellular type double positive for both functional ICs and PCs markers (H ϩ -ATPase/AE-1/Foxi1 and AQP2/AQP4, respectively). This cell type is located along the entire CD in association with the long-row pattern of A-IC. It maintains a cellular ultrastructure similar to A-IC. The level of expression of these cells follows the time course of the reversal of the cellular changes. Thus the double-marked cell could represent an intermediate element driving the conversion of A-ICs to PCs. This is, to our knowledge, the first in vivo characterization of this cellular type.
MATERIALS AND METHODS

Animal Study
The animal experiment was performed in accordance to the licenses issued by the Danish Ministry of Justice. Male Munich-Wistar rats were stabled at 23°C and maintained at 12-h day-light cycle. During the first 28 days (NDI-induction period) the rats of the experimental group (n ϭ 25) were fed a LiCl-enriched diet containing 40 mmol/kg dry food for 7 days and then 60 mmol/kg dry food, as previously described (6, 15) , plus free access to a salt block for the remaining 21 days. An equal group of rats (control group) received normal rat chow (Altromin 1324; Altromin Specialfutter) along the same period (Figure 1 ). At the end of the NDI-induction period, five rats from each group were randomly assigned to five different protocols receiving control food (NDI-recovery period). The rats were killed at: day 0 [the last day of the NDI-induction period, protocol 1 (P1) Fig. 1] ; day 6 (P2); day 12 (P3); day 19 (P4); and day 28 (P5).
In the last 3 days of each protocol, rats were housed individually in metabolic cages and physiological parameters were measured the last 24 h.
Urine and Blood Analysis
Blood was collected through the aorta before perfusing of the animals. Sodium, potassium, and serum and urinary osmolality were measured at Skejby University Hospital, Aarhus, Denmark. Serum concentrations of sodium and potassium were determined using a Vitros 950 analyzer (Johnson & Johnson Clinical Diagnostics, Rochester, NY). Urinary concentrations of sodium and potassium were determined by standard flame photometry (Eppendorf FCM6341; Eppendorf-Netheler-Hinz, Hamburg, Germany). The urine and plasma osmolality was measured with a cryoscopic osmometer (Osmomat 030; Gonotech, Berlin, Germany). Serum lithium was measured by atomic absorption spectrophotometry at Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Immunohistochemistry
Rats were anesthetized by isofluoran. The right kidney was collected for immunoblotting. Then, the left kidney was washed by retrograde perfusion via the abdominal aorta by 0.01 M PBS (pH 7.4) and then fixed by 3% paraformaldehyde (17) .
Single labeling. Sections were incubated with primary antibodies as follows: rabbit polyclonal anti-AQP2 antibody (7661AP; dilution 1:3,000; Ref. 16); mouse monoclonal anti-proliferating cellular nuclear antigen (PCNA) antibody (dilution 1:16,000; Sigma-Aldrich, St. Louis, MO); and rabbit polyclonal anti-apoptosis inducing factor-1 (AIF-1) antibody (dilution 1:100; Santa Cruz Biotechnology, Santa Cruz, CA). Labeling was visualized with goat anti-rabbit peroxidaseconjugated secondary antibody and 3,3=-diaminobenzidine (DAB).
Double labeling. For light microscopy, sections were incubated with anti-AQP2 antibody (7661AP, dilution, 1:1,000) followed by incubation with goat anti-rabbit peroxidase-conjugated secondary antibody and DAB (brown color). The potential remaining peroxidase from the first staining was removed by incubating the sections in 3.5% H 2O2. After blocking for endogenous biotin (Biotin Blocking System; Dako, Glostrup, Denmark), sections were incubated with biotinylated H ϩ -ATPase antibody (7659AP; dilution 1:25; Ref. 5) and labeling was visualized by horseradish peroxidase-conjugated streptavidin (Dako) and Vector SG substrate (blue-gray color). Double labeling was also performed with goat anti-Foxi1 antibody (dilution 1:200; ab20454; Abcam) and 1) rabbit polyclonal anti-AQP4 antibody (dilution 1:2,000; Alomone Laboratories), or 2) H ϩ -ATPase antibody (7659AP; dilution 1:1,000; Ref. 5), respectively.
For immunofluorescent double labeling, sections were incubated with 1) rabbit polyclonal anti-AE-1 antibody (758AP; dilution 1:25; Ref. 5 ) and biotinylated anti-AQP2 antibody (dilution 1:200), or 2) rabbit polyclonal anti-AQP4 antibody (dilution 1:2,000; Alomone Laboratories) and biotinylated H ϩ -ATPase (dilution 1:100). Sections were incubated with the first primary antibody followed by incubation with goat-anti rabbit Alexa 488-conjugated secondary antibody. Blocking for endogenous biotin was performed, and sections were incubated with the respective biotinylated primary antibodies followed by incubation with Alexa 546-conjugated streptavidin (Molecular Probes, Invitrogen, Carlsbad, CA).
Triple labeling. Sections were incubated with rabbit polyclonal anti-AQP4 (dilution 1:2,000) and goat polyclonal anti-Foxi1 antibodies (dilution 1:100) followed by incubation with donkey-anti rabbit Alexa 555-and donkey-anti goat Alexa 488-conjugated secondary antibodies (Molecular Probes, Invitrogen). Blocking of potential unbound sites on the goat-anti rabbit Alexa 555-conjugated secondary antibody was performed by incubation with rabbit serum (X0902; Dako). Sections were blocked for endogenous biotin (X0590, Dako Biotin Blocking System Kit) and incubated with biotinylated rabbit polyclonal H ϩ -ATPase (dilution 1:200). This was followed by incubation with Alexa 633-conjugated streptavidin (Molecular Probes, Invitrogen).
Quantification of AQP2-and H ϩ -ATPase-Positive Cells on Light Microscopical Sections
Apical AQP2 and H ϩ -ATPase labeling was used as marker of PCs and ICs, respectively, and double-labeled sections were used for cellular counting. The counting of cells exclusively positive for either AQP2 or H ϩ -ATPase was performed in the proximal part of the inner medulla (IM-1) using a ϫ25 objective. Only nucleated cells were counted. The cellular fraction was calculated by dividing the number of the labeled cells by the total number of nucleated cells of the CD (6) . The average total number of counted cells per rat (section) was as following: P1: experiment (exp.) 729 Ϯ 38 (n ϭ 5) and control 639 Ϯ 110 (n ϭ 4); P2: exp. 716 Ϯ 35 (n ϭ 5) and control 528 (n ϭ 2); P3: exp. 856 Ϯ 59 (n ϭ 4) and control 703 Ϯ 29 (n ϭ 4); P4: exp. 779 Ϯ 94 (n ϭ 5) and control 479 Ϯ 25 (n ϭ 5); and P5: exp. 812 Ϯ 90 (n ϭ 5) and control 571 Ϯ 42 (n ϭ 5).
Selection Criteria for Identification of Double-Labeled Cells on Fluorescent-Stained Sections
The identification of the double-labeled cells was carried out after excluding conditions of uncertainty of the labeling. We included only cells located along round transversal-cut tubules or along the straight part of longitudinal-cut tubules, excluding corners that were not cut sharply and where cellular overlapping may occur. Tubules without a clear visible luminal space and cells showing interruption of the labeling in their apical or basolateral domain were excluded. Quantification of the double-labeled cells was performed under the ϫ40 objective throughout the whole kidney section.
Quantification of Foxi1/AQP4-Positive Cells
Counting of cells positive for both Foxi1 and AQP4 was performed in the inner stripe of the outer medulla (ISOM) using a ϫ40 objective. Only nucleated cells were counted. The cellular fraction was calculated by dividing the number of double-labeled cells by the total number of nucleated cells of the CD. The average total number of counted cells per rat (section) was as following: P1: exp. 257 Ϯ 8 (n ϭ 5) and control 275 Ϯ 41 (n ϭ 4); P2: exp. 261 Ϯ 14 (n ϭ 5) and control 235 (n ϭ 2); P3: exp. 236 Ϯ 9 (n ϭ 4) and control 299 Ϯ 30 (n ϭ 4); P4: exp. 267 Ϯ 12 (n ϭ 5) and control 222 Ϯ 10 (n ϭ 5); P5: exp. 322 Ϯ 18 (n ϭ 5) and control 320 Ϯ 26 (n ϭ 5). , the rats of the experimental group (n ϭ 25) were fed a LiCl-enriched diet containing 40 mmol/kg dry food for 7 days and then 60 mmol/kg dry food for 21 days. A control group (n ϭ 25) received normal rat chow along the same period. Rats were killed at days 0, 6, 12, 19 , or 28 of the NDI-recovery period (during this period they were fed with normal rat chow).
Preparation of Tissue for Immunoelectron Microscopy
The ISOM was cut out from paraffin embedded kidney blocks and placed on a heating plate for 1 h at 60°C followed by reincubation in paraffin for 5 h at 60°C to ensure later a complete deparafinizing process. Tissue was deparaffinized in xylene overnight and then progressively rehydrated in ethanol. Before freezing in liquid nitrogen, the tissue was infiltrated with 2.3 M sucrose in 0.01 M PBS pH 7.4 overnight at 4°C, then minced, and further immersed in the same solution of sucrose at room temperature. Cryoultramicrotom sections (70 -100 nm) were incubated overnight with rabbit polyclonal anti-AQP4 antibody (dilution 1:400) followed by incubation with goat-anti rabbit antibody conjugated to 10 nm gold particles (BB International, Cardiff, UK). After blocking for endogenous biotin (Biotin Blocking System; Dako), sections were incubated overnight at 4°C with biotinylated H ϩ -ATPase antibody (dilution 1:80). Labeling was visualized by use of goat anti-biotin (5 nm; BB International). Grids were covered and stained in a methylcellulose/uranyl acetate solution (21) . Single labeling was also performed with the respective primary antibodies to rule out potential background artefact.
Western Blotting
Whole kidney was homogenized in dissection buffer (0.3 M sucrose, 25 mM imidazole, and 1 mM EDTA, pH 7.4) containing inhibitors of protease (leupeptin and Pefabloc SC) and phosphatase (Sigma-Aldrich) and centrifuged at 1,000 g for 10 min. Precasted 12% gels were used for electrophoresis. After transferring by electroelution to a PVDF membrane (Millipore, Billerica, MA), blots were blocked for 1 h with 5% milk in PBS-T and incubated with primary antibodies overnight (anti-AQP2 antibody, dilution 1:1,000 or anti-H ϩ -ATPase, dilution 1:1,000). Blots were incubated with fluorophore-conjugated secondary antibodies (Alexa 680 goat anti-rabbit; Invitrogen) and scanned using an Odyssey Infrared Imaging system (LI-COR). For detection of AQP4, whole kidney homogenate was centrifuged at 17,000 g for 30 min and the pellet was resuspended in dissection buffer including inhibitors as indicated above. Primary anti-AQP4
antibody was used at a dilution 1:1,000 (Alomone Laboratories). The membranes were subsequently incubated for 1 h with horseradish peroxidase-conjugated goat anti-rabbit IgG antibody (P448; Dako), and labeling was visualized using an enhanced chemiluminescence system. Bands at 31-34 kDa representing the AQP4 protein were scanned. Quantity One program was used to quantify band intensity. Coomassie staining was run for assessing equal protein concentration.
Statistical Analysis
Values are represented as means Ϯ SE. Data were analyzed by one-way ANOVA plus Tukey posttest and unpaired t-test. P Ͻ 0.05 was considered significant.
RESULTS
Serum and Urinary Physiological Parameters
After 1 mo of Li ϩ treatment, serum Li ϩ was 0.87 Ϯ 0.18 mM in the experimental group, whereas it was not measurable in the control group. Already after 6 days of recovery, Li ϩ was not detectable anymore in the experimental group. No differences were seen for serum Na ϩ , K ϩ , and osmolality in any of the protocols (Table 1 ). The experimental group developed progressively a urinary concentration defect during the Li ϩ -induction period. As shown previously (5), our data confirm that after 15 days of Li ϩ treatment, rats become polyuric (414.2 Ϯ 53.9 vs. 26.5 Ϯ 1.7 l·kg Ϫ1 ·min
Ϫ1
; n ϭ 25; P Ͻ 0.001) in parallel with decreased urine osmolality (259 Ϯ 24 vs. 1,930 Ϯ 80 mosmol/kgH 2 O; n ϭ 25; P Ͻ 0.001). At the end of the induction period, the urine concentrating defect worsens in Li ϩ -fed animals ( Table 1 ). This defect reversed progressively. At 6 days of recovery both the urinary volume and osmolality were still significantly affected in the experimental group, but they normalized on the level of the control group after 12 days and at later time points. (15) . Protein expression was investigated in whole kidney samples. At the end of the Li ϩ -induction period the AQP2 protein expression was 60% lower in the Li ϩ -treated rats compared with the control group (P Ͻ 0.05; Table 2 ). This downregulation was not detectable during the recovery period. H ϩ -ATPase protein expression was upregulated in the experimental group at the end of Li ϩ treatment (P Ͻ 0.01; Table 2 ) and the upregulation persisted up to 12 days of recovery. After 19 and 28 days of recovery, H ϩ -ATPase expression was similar to control levels. Lithium induced a marked increase in AQP4 expression (Table 2) with the most pronounced upregulation in the cortex (data not shown). An AQP4 upregulation was also seen during the recovery period up to 19 days of recovery, whereas no significant changes between experimental and controls animals were seen at 28 days of recovery (Table 2) .
Cellular Composition of the CD During Recovery
Our present study confirmed previous results (6, 12) showing a reorganization of the cellular composition of the CD after 1 mo of Li ϩ treatment resulting in an increased fraction of ICs and a decreased fraction of PCs (P Ͻ 0.05; Table 3 , counted in the IM-1). In addition, the large number of ICs was not interposed between PCs as normal but was organized in a pattern of long rows of ICs located next to each other. This long-row pattern localizes along all the segments of the CD until the IM-1 (Fig. 2 ) in longitudinally and transversally cut tubules. During the recovery period, the frequency of the long-row pattern decreased progressively in parallel with a decrease in the frequency of ICs. They became shorter until the common pattern of interposition of one IC in between PCs was predominant (Fig. 2) . At days 19 and 28 of recovery, only ICs in doublets remained rarely.
AQP2-and H ϩ -ATPase-positive cells were counted in the IM-1: the fraction of ICs was higher in the experimental group (P Ͻ 0.05) in parallel with a lower fraction of PCs (P Ͻ 0.05) after 1 mo of lithium treatment (Table 3) . At this time point we found ϳ1% of the cells negative for both AQP2 and H ϩ -ATPase. These cells could represent either PCs expressing a nondetectable amount of AQP2 because of maximum Li ϩ effect at this time point or a different cellular type. After 6 days of recovery these cellular changes persisted (20% experimental vs. 7% control group). Here no statistic test was performed because of the exiguity of the n in the control group. However, the frequency of ICs in the control group was in line with the other studied time points (Table 3 ) and with other reports where it was ϳ10% in IM-1 (7) . Variation in the expression of ICs and PCs was significantly different between the experimental and control group after 12 days of recovery (Table 3) . At later time points (19 and 28 days of recovery) alteration in the cellular counts for both PCs and ICs tended towards the control level (Table 3 ). In addition some cells were double positive for both AQP2 and H ϩ -ATPase in the IM-1. They Values are means Ϯ SE; n power is indicated in parenthesis. Cellular fraction is expressed as the number of labeled cells over the total number of nucleated collecting duct cells. IM-1, proximal part of the inner medulla. *P Ͻ 0.05; †P Ͻ 0.01. D) . At the end of the Li ϩ diet, the H ϩ -ATPasepositive cells (grey-blue) form a long-row pattern (A), while in the control group (B) they are located in between aquaporin-2 (AQP2)-positive cells (brown). During the recovery period, the length and the frequency of the long-row pattern decreases progressively in the experimental group. After 19 days of recovery, the long-row pattern is not detectable either in the experimental group (C) or in the control group (D). At the end of the Li ϩ diet, AQP2 labeling in the experimental group (A) is lower compared with the control group (B; a relatively high concentration of the AQP2 antibody was used to ensure that cells that expressed even very low levels of AQP2 were detected).
accounted for about 0.3 and 1% of all counted nucleated cells of the CD in IM-1 at 6 and 12 days of recovery, respectively.
Cells Expressing Both IC and PC Markers Are Morphologically Similar to ICs
During the recovery period we found the presence of a novel cellular type in the CD. This cell type expresses markers specific for both ICs and PCs. As markers of A-IC we chose the basolateral expression of AE-1 and the cytosolic/apical expression of H ϩ -ATPase, while for PCs we used apical localization of AQP2 and basolateral AQP4. Double labeling with anti-AQP2/anti-AE-1 or anti-H ϩ -ATPase/anti-AQP4 antibodies resulted in the identification of some cells expressing unusually both proteins (Fig. 3, C and D, arrows) . No atypical intracellular localization of these markers was found. These cells were identified in CD in cortex, outer medulla, and IM-1. They were mainly located in CD of the ISOM. They were almost exclusively identified in rats that have been treated with lithium. Sporadically, they were identified in the control group (about 1-2 cells/whole kidney section) mainly in the cortex. The double-labeled cells were often located between two A-ICs (middle of long-row pattern) but could also be interpolated between one IC and one PC at the edge of the long-row pattern. The highest frequency of this cellular type was recorded at 6 days of recovery, and it became less frequent along the recovery period (Fig. 3E) . Although a significant difference was only observed in the total amount of AQP2/AE-1-positive cells between days 0 and 6, the tendency was similar for H ϩ -ATPase/AQP4-positive cells. However, the AQP2/AE-1-positive cells were more abundant than the H ϩ -ATPase/AQP4-positive cells.
The ultrastructure of this cell type was examined with both differential interference contrast (DIC) and immunoelectron microscopy. Figure 4 shows a representative confocal microscopical image and a corresponding DIC image of a CD from ISOM. In the DIC image, the double-labeled cell (Fig. 4B , arrow) appeared with a rough intracellular structure similar to the ICs (square) likely representing a high amount of mitochondria. This was in contrast with a smoother structure of the PCs (asterisk). The ultrastructure of this cellular type was further investigated by immunoelectron microscopy using ISOM sections. A double labeling with anti-H ϩ -ATPase and anti-AQP4 antibodies was performed, and the two proteins were detected with 5-and 10-nm gold particles, respectively. Figure 5A shows a cell (asterisk) with apical H ϩ -ATPase expression (Fig. 5C, inset, arrows) and basolateral AQP4 expression (Fig. 5D, inset, arrows) . True ICs were identified by apical H ϩ -ATPase expression and true PCs by basolateral AQP4 expression. As indicated by DIC, the double-labeled cell was rich in mitochondria similar to the ICs, while PCs appeared with fewer mitochondria. Thus the cells expressing both PC and IC markers have an ultrastructure similar to ICs. Figure   Fig 5E, inset, shows that there is no basolateral labeling in the cell located between the double-labeled cell and the IC. Thus this confirms that the basolateral AQP4 staining in Fig. 5D , inset, is from the double-labeled cell (asterisk). Figure 5B shows a cell from a different tubule with an ultrastructure similar to ICs. This cell is also double positive for AQP4 at the basolateral membrane (Fig. 5G, inset, arrows) and for H ϩ -ATPase at the apical membrane and in the cytoplasm (Fig. 5F, inset, arrows) .
Proliferation and Apoptosis
We evaluated the proliferation rate by immunohistochemistry using anti-PCNA antibody. We found a large number of PCNA-positive cells throughout all the renal zones at the end of the Li ϩ treatment in the experimental group (illustrated for IM and ISOM in Fig. 6, A and B) . They were mainly located along the CD. Only few PCNA-positive cells were seen in the control group (Fig. 6 , B: IM and D: ISOM). During the recovery period, the number of PCNA-positive cells was similarly sparse and no major differences were seen between the groups (illustrated for P2 in IM and ISOM in Fig. 6, E and F) . We further examined the rate of apoptosis by immunohistochemistry using an anti-AIF-1 antibody. In both groups, AIF-1-positive cells were seen only rarely and no specific difference in distribution and frequency was detected between the two studied groups in any of the protocols (illustrated for P1 and P2 in IM and ISOM in Fig. 7, A-H) . Thus neither proliferation nor apoptosis appears to play major roles in the recovery from Li ϩ -induced NDI.
Foxi1 is Expressed in Some AQP4-Positive Cells in the Recovery Phase
To investigate a potential role of the forkhead transcription factor Foxi1 in the recovery phase, we have performed double labeling with anti-Foxi1 and anti-AQP4 or anti-H ϩ -ATPase antibodies, respectively (Fig. 8) . As previously shown (2, 23), nuclear Foxi1 labeling was observed in H ϩ -ATPase-positive cells in both experimental and control animals in all the protocols (shown for P2, ISOM in Fig. 8, A and B) . However, some AQP4-positive cells were positive for Foxi1 expression in the experimental group mainly at 6 and 12 days of recovery [shown for P3, outer stripe of outer medulla in Fig. 8C ]. This was more rarely seen in the corresponding control animals (Fig. 8D) . Cellular counting of CD cells in the ISOM revealed a significant higher fraction of Foxi1/AQP4-positive cells in the experimental animals at day 12 of recovery compared with the corresponding controls (P3: exp. 3.6 Ϯ 0.22 vs. control 1.3 Ϯ 0.43%; P Ͻ 0.01). Due to the low n number (n ϭ 2) in the controls, statistical analysis was not performed at 6 days of recovery (P2: exp. 5.3 Ϯ 1.1 vs. control 2.5%). No significant changes were seen at day 0 (P1: exp. 0.40 Ϯ 0.14 vs. control. 2.7 Ϯ 1.3%; ns), at day 19 (P4: exp. 0.89 Ϯ 0.18 vs. control 0.77 Ϯ 0.40%; ns), and at day 28 (P5: exp. 0.22 Ϯ 0.16 vs. control; 1.04 Ϯ 0.55%; ns).
Some Foxi1/AQP4-Positive Cells Also Express H ϩ -ATPase
To examine whether the Foxi1/AQP4-positive cells also contained H ϩ -ATPase, triple labeling for Foxi1, AQP4, and H ϩ -ATPase was performed (Fig. 9 , A, experimental group and B, control group). As shown in Fig. 8, Foxi1 was present in H ϩ -ATPase-positive cells in the ISOM of both experimental and control animals at 12 days of recovery (Fig. 9, A and B,  open arrowheads) . Some Foxi1/AQP4-positive cells did not contain H ϩ -ATPase (Fig. 9A, arrowhead) , whereas other Foxi1/AQP4-positive cells did label positive for H ϩ -ATPase (Fig. 9A, arrow) . This could be suggestive that the double staining for AQP4/Foxi1 and AQP4/H ϩ -ATPase identify the same cell type with an ultrastructure similar to ICs.
DISCUSSION
The development of Li ϩ -induced NDI usually hampers its usage in clinical practice. Polyuria usually relieves after lowering or dismissing the Li ϩ dosage. In this study we focused on the mechanisms underlying the recovery phase of the Li ϩ -induced NDI. precursor is normally present along the CD or whether fully differentiated cells could reconvert into such cellular type for further terminal differentiation. We have characterized a novel cell type that expresses markers for both IC and PC and that has the morphology of IC. This cell could represent an intermediate cell in the conversion of IC to PC during the recovery from lithium-induced NDI.
Reversal of Li ϩ -Induced Polyuria
We showed here that the urinary concentrating defect reverts after 12 days of recovery. The improvement of the urine concentrating ability in the experimental group was associated by the restoration of the AQP2 protein expression. At 6 days of D, F, and H) at the end of Li treatment (A-D) and after 6 days of recovery (E-H). PCNA nuclear staining was seen at the end of lithium treatment in IM and ISOM in the experimental animals (A and C), whereas sparse or no labeling was seen in control animals and after 6 days of recovery (B, D, E, and H).
recovery differences in the AQP2 protein expression were no more seen between the two groups of rats as shown by Western blotting. However, at this time point, the experimental group was still polyuric. The detection of AQP2 in whole kidney samples could blind a possible zonal variation in the expression of this protein. Immunohistochemistry showed a reduced AQP2 labeling at 6 days of recovery in the IM while no differences were observed in the other kidney zones of the experimental rats (data not shown). Supporting this view is a previous study from Marples et al. (15) that showed, in a similar setting, that AQP2 protein abundance was still downregulated in the IM after 7 days of recovery. Another possible explanation to these findings could be related to a lower interstitial osmolality of the inner medullary collecting duct due to polyuriainduced medullary washout. The AQP4 expression was highly upregulated after lithium treatment especially in the cortex and the induced expression persisted during the recovery phase up to 19 days. The increased AQP4 levels seen in the toxicity phase indicate that Li ϩ only interferes with pathways involved in AQP2 regulation and not with the regulation of AQP4. The upregu- lation of AQP4 could be due to elevated vasopressin levels seen doing lithium administration (22) .
Reversal of Li ϩ -Induced Cellular Changes in the CD
Besides the development of the urinary concentration defect, Li ϩ treatment induces a cellular reorganization of the CD. As shown previously an increased fraction of A-ICs appears after 1 mo of Li ϩ treatment and reverts after an additional month of Li ϩ washout (6). Here we defined the time course of this reversal. We found that the increased number of A-ICs in the experimental group persisted throughout the recovery period until day 19. This finding could be extended to the other renal zones. Supporting these data is the similar time course of the increased expression levels of H ϩ -ATPase. In parallel the A-ICs formed long rows of cells located next to each other at the end of Li ϩ treatment as shown previously (6) . This cellular pattern was less frequent after 19 days of recovery. During the recovery period the reduction in the number of A-ICs and the reduced length of the rows of A-ICs ran in parallel. Apparently this cellular reversal does not seem to be related to tubule remodeling by proliferation/apoptosis. We could see substantial changes in the proliferation rate of the CD only at the end of the Li ϩ treatment, confirming previous data (5) .
During this time frame (up to 19 days), we identified the presence of a novel cellular type, expressing both markers of PC and ICs. These cells were seen mainly in the experimental group while they were quite rare in the control group. The time course of their appearance and their location in continuity with the A-IC rows and the ultrastructure could suggest that they drive the reversal of the long-row pattern of the A-IC. In fact these cells were mainly seen at the first time point investigated after the Li ϩ -diet (6 days of recovery) and they were less frequent up to the 19th day of recovery. They were often located in between A-ICs (middle of the row), but they were also located at one edge of a long row of A-IC. They could represent a transition phase from the A-ICs towards the PCs. The ultrastructure of this cell type showed multiple components of similarity with the fully differentiated A-IC. The number of mitochondria in this double-positive cell resembles the typical structure of A-IC. Taken together, these findings could suggest that, after the Li ϩ -injuring effect, ICs could convert into PCs. This mechanism could include first transcription of genes normally activated only in PCs such as AQP2 and AQP4, while keeping the fundamental structure of a typical A-IC. At a later stage, changes in the intracellular structure could result in the eventual final conversion of A-IC to PCs. Foxi1 is a transcriptional factor necessary for the fully differentiation and normal function of ICs in the mature kidney (2) . The protein has previously been shown to be expressed in ICs and not in PCs (2) . Consistently, we also observed Foxi1 expression in ICs in the present study.
Here we showed that some Foxi1-positive cells also express AQP4. These AQP4/Foxi1 double-labeled cells present a sim- ilar timing of appearance as the AE-1/AQP2 and H ϩ -ATPAse/ AQP4-positive cells. In addition, we proved that some, but not all, of the AQP4/Foxi1 are also positive for H ϩ -ATPase, suggesting that, at least in part, the used markers identify the same cell type. Finally one could speculate that the double-and triple-positive cells identified by those different markers could represent a different stage of conversion process from ICs into PCs. This conclusion needs a deeper investigation.
The plasticity of the renal epithelial cells has been proposed in renal healing mechanism in response to acute kidney injury conditions both in vitro (3, 25) and in vivo models (8, 9, 13) . Recently, evidence showed that the renal tubular epithelium participates in the epithelial mesenchymal transition process (18, 20) as already well studied in lung (4). We hypothesize that epithelial cells of the CD, namely the ICs, as an effect of their plasticity could convert into another cell with the same embryologic origin (the PC). Our data are in accordance with a recent model presenting a cell double labeled with AQP2 and H ϩ -ATPase as a common precursor of PCs and ICs (26) . In conclusion we provide here evidence for the presence of a novel cellular type expressing both functional markers of A-ICs and PCs. This is to our knowledge the first identification and characterization in vivo of this double-labeled cell type. These cells could drive the reversal of the cellular changes in the recovery period of the Li ϩ -induced NDI, and they could represent a transition phase in the cellular conversion process of A-ICs into PCs. The conversion into PCs could be a further level of plasticity of the A-IC.
